checkAd

    EQS-Adhoc  144  0 Kommentare HBM portfolio company Ambrx Biopharma raises USD 126 million in initial public offering on New York Stock Exchange - Seite 2

    Disclaimer

    The publication is for information purposes only and does not constitute an offer to sell or a solicitation to buy or subscribe for securities. This news release does not constitute a prospectus within the meaning of Art. 35ff FinSA, or securities prospectus in the sense of the German securities prospectus law. This news release and the information contained therein is not intended for distribution to the United States of America (USA) or within the USA and may not be distributed or forwarded to US persons (including legal persons) or to publications with a general distribution in the USA. This news release is not an offer or solicitation to buy securities in the United States. HBM Healthcare Investments AG's securities were not issued in accordance with the U.S. U.S. securities laws, and may not be sold, offered for sale, or delivered in the U.S. or to U.S. individuals without prior registration or without a registration exemption. Some information quoted was obtained from external sources HBM considers to be reliable. HBM cannot guarantee the adequacy, accuracy, timeliness or completeness of or be held responsible or liable for errors of fact regarding such data and information obtained from third parties, and this data may change with market conditions.



    End of ad hoc announcement
    Language: English
    Company: HBM Healthcare Investments AG
    Bundesplatz 1
    6300 Zug
    Switzerland
    Phone: +41438887171
    Fax: +41438887172
    E-mail: info@hbmhealthcare.com
    Internet: https://www.hbmhealthcare.com
    ISIN: CH0012627250
    Valor: 1262725
    Listed: SIX Swiss Exchange
    EQS News ID: 1209888
    Seite 2 von 3



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc HBM portfolio company Ambrx Biopharma raises USD 126 million in initial public offering on New York Stock Exchange - Seite 2 EQS Group-Ad-hoc: HBM Healthcare Investments AG / Key word(s): IPO HBM portfolio company Ambrx Biopharma raises USD 126 million in initial public offering on New York Stock Exchange 21-Jun-2021 / 06:45 CET/CEST Release of an ad hoc announcement …

    Schreibe Deinen Kommentar

    Disclaimer